With time, marrow HSC loss due to differentiation or migration and sequestration in the spleen, and continued megakaryocyte stimulation by the elevated plasma THPO, could produce a PMF phenotype, regardless of the MPN driver mutation. Here, THPO is linked to myeloproliferative neoplasm.